Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person MYH9 and RNF213 are unusual fusion partners of ALK that have...
| Class:Id | Summation:9724088 |
|---|---|
| _displayName | MYH9 and RNF213 are unusual fusion partners of ALK that have... |
| _timestamp | 2023-10-14 19:29:17 |
| created | [InstanceEdit:9724087] Rothfels, Karen, 2021-03-22 |
| modified | [InstanceEdit:9851215] Rothfels, Karen, 2023-10-14 |
| text | MYH9 and RNF213 are unusual fusion partners of ALK that have been identified in anaplastic large cell lymphoma (ALCL) (Lamant et al, 2003; Cools et al 2002). The MYH9 gene encodes a non-muscle myosin heavy chain with roles in cell division, motility and secretion. Although MYH9 is capable of oligomerization by virtue of an N-terminal coiled-coil region, this domain is not present in the ALK fusion protein. The ALK fusion also lacks kinase activity as assessed by in vitro assays. Despite both of these facts, the fusion protein is constitutively phosphorylated in vivo. How or whether this fusion proteins functions in oncogenic transformation remains to be elucidated (Lamant et al, 2003). Similarly, the RNF213-ALK fusion has no recognizable protein domains that might contribute to dimerization, and the endogenous function of RNF213 is not known. LIke the MYH9 fusion, the role of the RNF213-ALK fusion in promoting transformation is not yet clear (Cools et al, 2002). |
| (summation) | [BlackBoxEvent:9724090] MYH9- and RNF213-ALK fusions are phosphorylated [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by MYH9 and RNF213 are unusual fusion partners of ALK that have... (9724088)
